Literature DB >> 23257230

Reanalysis of TransVax immunogenicity.

Mohamed A Kharfan-Dabaja, Michael Boeckh, Marissa B Wilck, Amelia A Langston, Alice H Chu, Mary K Wloch, Larry R Smith, Alain P Rolland, Richard T Kenney.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23257230     DOI： 10.1016/S1473-3099(12)70296-7

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  4 in total

1.  Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?

Authors:  Mark R Schleiss
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

Review 2.  Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases.

Authors:  Thomas Grunwald; Sebastian Ulbert
Journal:  Clin Exp Vaccine Res       Date:  2015-01-30

Review 3.  Preventing transfer of infectious agents.

Authors:  Joachim Denner; Nicolas J Mueller
Journal:  Int J Surg       Date:  2015-08-24       Impact factor: 6.071

4.  Clinical Development of a Cytomegalovirus DNA Vaccine: From Product Concept to Pivotal Phase 3 Trial.

Authors:  Larry R Smith; Mary K Wloch; Jennifer A Chaplin; Michele Gerber; Alain P Rolland
Journal:  Vaccines (Basel)       Date:  2013-09-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.